Stocks in play: Aptose Biosciences Inc

Announced it has entered into an equity distribution agreement with JonesTrading Institutional Services LLC, as agent. Under the terms of the Equity Distribution Agreement, the Company may, from time to time, issue and sell through the Agent, common shares of the Company through “at-the-market” distributions on the Nasdaq Capital Market. Aptose will determine, at its sole discretion, the time, price and number of Common Shares to be sold under the Offering. In connection with the Offering, Aptose filed a prospectus supplement with the U.S. Securities and Exchange Commission, qualifying the offer and sale of Common Shares having an aggregate offering price of up to US$50 million. Aptose Biosciences Inc shares T.APS are trading -$0.08 at $0.87.

Read:

• Latest Set of FDA Fast Track Designations Causing Optimism in Biotech Sector

• Biotech Sector to Unveil New Data and Developments at 2022 SABCS in San Antonio

• Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer

• New Biotech Sector Drug Combinations Target a Drop in Pancreatic Cancer Mortality Rates

• Highly Sought After Natural Ingredients Appearing in More Plant-Based Products Across North America